AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 33 min read$WAT

Waters: Q3 Earnings Snapshot

Waters Corp. (WAT) reported Q3 earnings of $81M, or 82 cents per share, beating expectations. Revenue was $1.77B, also exceeding forecasts. The company expects Q4 earnings of $4.58-$4.68 per share and revenue of $1.8B-$1.9B.

Original reporting
finance.yahoo.com
Published Nov 3, 2026, 11:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Waters: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$WATBullishMed
01

Why it matters

The key trading inputs are the beat versus analyst expectations and the stated EPS and revenue ranges for the current quarter ending in December, fiscal Q4, and full-year.

02

Market read

Guidance ranges can drive estimate revisions and near-term positioning for WAT around the next earnings cycle.

03

What to watch

The article does not break out segment performance, margins, or cash flow, which can drive post-earnings revisions even when EPS beats.

Relevance 9/10Novelty 8/10Timing: reported Tuesday, guidance for current quarter and fiscal fourth quarter

Background

Waters is a maker of products used in drug discovery and development, and this piece summarizes its Q3 earnings and forward guidance.

Company-level read

Ticker impact

$WATBullishHigh confidence
Context

Waters reported Q3 EPS of $4.10 (adjusted) and revenue of $1.77B, beating estimates, and issued Q4 and full-year guidance ranges.

Expected impact

Likely upward bias as the market reprices expectations toward the company’s provided Q4 and full-year guidance ranges.

Evidence & confidence

The article contains the company’s own quarterly results and forward guidance ranges, which are direct inputs to earnings models and near-term positioning.

Market effects

Sector

Signals demand and pricing resilience in drug discovery and development tools, which can modestly influence sentiment across life-science instrumentation peers.

Regional

Limited regional spillover; primarily affects US-listed biotech tools sentiment.

Global

Low global macro linkage; mostly company-specific guidance for a US-listed instrument maker.

Counterpoint

What could challenge this read

A beat may already be partially priced; traders may focus on whether guidance implies margin or demand constraints not visible in headline EPS.

Key entities

  • company
    Waters Corp.

    Reported Q3 earnings and provided EPS and revenue guidance for the current quarter, fiscal fourth quarter, and full year.

Read at source← All news

StoryWaters Corp reports Q3 2026 earnings beat, raises 2026 guidance and announces MOBILion acquisition

Also covered by

5 outlets

Related articles

NOV 3
$WATHighAI 8/10

Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results

WATERS CORP /DE/ (WAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highl

SEC EDGAR 8-K2 min
NOV 3
$WATHighAI 8/10

Waters Corp. Q3 Adjusted EPS Rises 21%; Raises Annual Outlook; Stock Up

Waters Corp. (WAT) reported Q3 net income fell to $81M ($0.82 EPS) due to costs, but adjusted EPS rose 21% to $4.10. Revenue hit $1.767B, with organic growth of 9%. The company raised its 2026 outlook, expecting organic revenue growth of 9.1% to 9.7% and adjusted EPS of $14.60 to $14.70. Shares rose 6% in pre-market trading.

rttnews.com2 min
NOV 3
$WATMed

Waters Acquires MOBILion Systems To Expand Proteomics Business

Waters Corp. (WAT) acquired MOBILion Systems to expand its proteomics business. The deal combines MOBILion's SLIM tech with Waters' Xevo MRT platform, aiming to enhance protein research. The LC-MS proteomics market is valued at $2B with high single-digit annual growth. Financial terms were not disclosed.

rttnews.com2 min
NOV 3
$WATHighAI 8/10

Waters beats Q3 estimates, raises full-year guidance

Waters Corporation (NYSE:WAT) reported Q3 adjusted EPS of $4.10, beating estimates by $0.10, with revenue of $1.77B, up 121% YoY. The company raised full-year 2026 guidance, expecting adjusted EPS of $14.60-$14.70 and revenue of $6.48B-$6.50B. Q4 guidance was mixed. Organic revenue grew 9%, driven by strong divisional performance. The company also acquired MOBILion Systems, Inc.

investing.com2 min
NOV 3
$WATHighAI 8/10

Waters earnings beat by $0.10, revenue topped estimates

Waters (WAT) reported Q3 EPS of $4.10, beating estimates by $0.10, with revenue at $1.77B, exceeding expectations. The company provided Q4 and FY 2026 guidance, with EPS and revenue estimates generally in line with or slightly above consensus. WAT's stock is up 12.47% over the last 3 months and 22.37% over the last 12 months.

investing.com2 min